Year: 2020

NEWMARKET, Ontario, Nov. 12, 2020 (GLOBE NEWSWIRE) — AirBoss of America Corp. (TSX: BOS) (the “Company” or “AirBoss”), a diversified manufacturer of rubber compound products and personal protective equipment, including to the U.S. defense and health care markets, today announced the appointment of Stephen M. Ryan, a highly regarded legal advisor based in Washington D.C., to its Board of Directors effective November 12, 2020.“Steve Ryan further enhances AirBoss’ expertise and insight in its work with government agencies, particularly in our growing presence in the U.S. marketplace. AirBoss will be able to benefit from Steve’s insights gained from his work and relationships resulting from his representations of numerous well-known multinational corporations in their interactions with various government agencies...

Third quarter 2020 revenue was $268 million, 32% lower than the $394 million reported in the third quarter of 2019.Adjusted EBITDA1 in the third quarter of 2020 was $17.8 million, 58% lower than the $42.4 million reported in the third quarter of 2019.Net loss2 in the third quarter of 2020 was $18.3 million (or loss per share of $0.26 diluted) compared with a net income of $6.5 million (or $0.09 earnings per share diluted) in the third quarter of 2019. Excluding the impact of restructuring cost and the adjustment for Argentina hyperinflationary accounting, adjusted net loss1 in the third quarter of 2020 was $11.2 million (or adjusted loss per share1 of $0.16) compared with adjusted net income1 of $6.0 million (or $0.09 adjusted earnings per share1) in the third quarter of 2019.The Company’s order backlog was $542 million at September 30,...

WOODCLIFF LAKE, NJ, Nov. 12, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — Timber Pharmaceuticals, Inc. (“Timber” or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, today provided a business update and announced financial results for the third quarter of 2020, ended September 30, 2020. John Koconis, Chief Executive Officer of Timber, commented, “During the third quarter the management team of Timber has been working hard on all fronts of the Company’s operations. This includes advancing our two ongoing Phase 2b clinical trials for orphan indications, exploring strategic options for the two assets acquired from BioPharmX Corp, and investigating options to improve the capital structure of the Company....

VANCOUVER, British Columbia, Nov. 12, 2020 (GLOBE NEWSWIRE) — First Majestic Silver Corp. (“First Majestic” or the “Company”) announced today that its Mexican subsidiary Primero Empresa Minera, S.A. de C.V. (“PEM”) has now been provided with written reasons for the decision made on September 23, 2020 by the Mexican Federal Court on Administrative Matters (“Federal Court”), nullifying the Advance Pricing Agreement (“APA”) concluded in 2012 between PEM and the Mexican tax authority, Servicio de Administracion Tributaria (“SAT”).The Federal Court’s decision directs SAT to re-examine the evidence and basis for the issuance of the APA with retroactive effect, for the following key reasons (i) SAT’s errors in analyzing PEM’s request for the APA and the evidence provided in support of the request; and (ii) SAT’s...

AUSTIN, Texas, Nov. 12, 2020 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (Nasdaq: SAVA) (the “Company” or “Cassava Sciences”), a clinical-stage biotechnology company focused on Alzheimer’s disease, today announced that it is commencing an underwritten public offering of shares of its common stock. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or the actual size or terms of the offering. The Company expects to grant the underwriters a 30‐day option to purchase up to an additional 15 percent of the shares of common stock offered in the public offering.Cantor Fitzgerald & Co. is acting as sole book-running manager for the proposed offering.Cassava Sciences intends to use the net proceeds, if any, from the sale of the shares of common stock...